To include your compound in the COVID-19 Resource Center, submit it here.

HBV-ABs: Phase I

XTL Biopharmaceuticals Ltd. (LSE:XTL), Rehovot, Israel
Product: HBV-ABs (XTL-001)
Business: Infectious diseases
Therapeutic category:

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE